Interaction between ketoconazole and domperidone and the risk of QT prolongation--important safety information
South African Medical Journal 96(7): 596
2006
ISSN/ISBN: 0256-9574 PMID: 16909179 Document Number: 595111
Document emailed within 1 workday
Related Documents
Runciman, B.; Merry, A.; Smith, A.M. 2001: Improving patients' safety by gathering information. Anonymous reporting has an important role Bmj 323(7308): 298Ashcroft, B.; Eistein, M.; Boreham, N. 2000: Reducing error, improving safety. Systems approach to intrapartum risk management is important Bmj 321(7259): 508
Magnasco, A.J.; Magnasco, L.D. 1986: Interaction of ketoconazole and ethanol Clinical Pharmacy 5(6): 522-523
Dieterle, W.; Mann, J. 2006: Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 44(7): 326-330
Tillement, J.P.; Albengres, E. 1995: Cyclosporin a and ketoconazole, drug interaction or therapeutical combination? Therapie 50(3): 185-189
Krautkrämer, H. 1984: When can exact information on treatment risk be dispensable? The federal court has further differentiated its legal stand on risk information Fortschritte der Medizin 102(34): 60-61
Elewski, B.; Ling, M.R.; Phillips, T.J. 2006: Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase IIi trial Journal of Drugs in Dermatology: Jdd 5(7): 646-650
Slovacek, L.; Priester, P.; Petera, J.; Slanska, I.; Kopecky, J. 2011: Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma Bratislavske Lekarske Listy 112(6): 353-354
Draelos, Z.ë D.; Feldman, S.R.; Butners, V.; Alió Saenz, A.B. 2013: Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study Journal of Drugs in Dermatology: Jdd 12(1): E1-E6
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Seebacher, C. 1986: Comparison of benefit against risk of ketoconazole therapy Therapia Hungarica 34(4): 227-232
Semmanaselvan, K.; Mukaddam, Q.I.; Naik, M. 2015: An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease Journal of the Association of Physicians of India 63(7): 27-32
Onishchenko, G.G. 2007: Important issues of biological safety Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 40-44
Hoel, T.; Andersen, B.M. 1997: Malaria prophylaxis--correct information is important Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(7): 1001-1002
Senathirajah, Y.; Bakken, S. 2011: Important ingredients for health adaptive information systems Studies in Health Technology and Informatics 169: 280-284
Ballard, E.C. 1997: Important considerations about nursing intelligence and information systems Studies in Health Technology and Informatics 46: 44-49
Kolb, C. 2000: Patient record for pacemaker patients. the most important basic information MMW Fortschritte der Medizin 142(48): 51-53
Frieling, W. 2009: Beyond 'meaningful use'. Regional health information exchanges just as important to healthcare IT Modern Healthcare 39(32): 22
Coulter, A. 1998: Evidence based patient information. is important, so there needs to be a national strategy to ensure it Bmj 317(7153): 225-226
Tanser, F.C.; Sueur, D. le 2002: The application of geographical information systems to important public health problems in Africa International Journal of Health Geographics 1(4): (9 December 2002)